Patients with scleroderma have reduced levels of Cathepsin L

Much of the research on scleroderma, a connective tissue disease that causes scarring, or fibrosis, has focused on the increased number of proteins promoting fibrosis in these patients. A Medical University of South Carolina (MUSC) research team took a different tact and measured the levels of an antifibrotic protein, Cathepsin L, in these patients.

Related Keywords

Carol Feghali Bostwick , Joe Mouawad , Kitty Trask Holt , Emily Henderson , University Of South Carolina , Scleroderma Research , Drug Administration , National Scleroderma Foundation , Medical University , South Carolina , Kitty Trask Holt Endowed Chair , Phd Student , Fibrosis , Scleroderma , Drugs , Education , Fibroblast , Hospital , Lungs , Medicine , Mh , Protein , Research , Heumatology ,